“PHENOTYPIC EVALUATION OF ANTIFUNGAL SUSCEPTIBILITY PATTERN OF Candida albicans ISOLATED FROM DIFFERENT CLINICAL SAMPLES BY KIRBY-BAUER DISC DIFFUSION AND BROTH MICRODILUTION METHOD TO FLUCONAZOLE AND AMPHOTERICIN B”

Q3 Pharmacology, Toxicology and Pharmaceutics
Prema Nandini, R.Sujatha
{"title":"“PHENOTYPIC EVALUATION OF ANTIFUNGAL SUSCEPTIBILITY PATTERN OF Candida albicans ISOLATED FROM DIFFERENT CLINICAL SAMPLES BY KIRBY-BAUER DISC DIFFUSION AND BROTH MICRODILUTION METHOD TO FLUCONAZOLE AND AMPHOTERICIN B”","authors":"Prema Nandini, R.Sujatha","doi":"10.47750/pnr.2023.14.02.337","DOIUrl":null,"url":null,"abstract":"Introduction: Candidiasis is a major fungal infection where Candida albicans is the major cause of infections in humans.  Candida albicans is an opportunistic pathogen under immune-compromised conditions and despite anti-fungal therapies, it has become lethal. Increase in the antimicrobial resistance in C. albicans is a matter of concern as it is in the human microbiome. \nAim and Objective: To determine the antifungal susceptibility pattern of Candida albicans isolated from different clinical samples against Fluconazole and Amphotericin B by Kirby Bauer disc diffusion method and Broth microdilution method. \nMaterials and Methods: This was a cross sectional study carried out in the Department of Microbiology at Rama Medical College Hospital and Research Centre Mandhana, Kanpur for a period of 1 year i.e, April 2018 to April 2019. A total of 70 isolates of Candida species from different clincal specimens like blood, BAL, urine, Pus, Et secreation and vaginal secreation were evaluated for its susceptibility against Fluconazole and Amphotericin B using Kirby Bauer disc diffusion method and Broth micro dilution method according to the CLSI guidelines 2018. \nResults: Out of 70 isolates of Candida species 29 (41.4%) isolates were confirmed to be C.albicans. The ratio of Males 18 (62%) was more as compared to that of the Females 11(37.9%) with the maximum age of 31-40 being affected the most followed by 41-50 and least in the age group above 61 years of age. The number of isolates was maximum in the urine sample.  A total of 12 (41.3%) samples of Candida were sensitive and 17 (58.6%) samples were resistant to Amphotericin B & 27(93%) samples of Candida were sensitive and 2(6.8%) samples were resistant to Fluconazole by Kirby bauer disc diffusion method. 28(96.5%) samples of Candida were sensitive and 1(3.4%) sample was resistant to Amphotericin B & 25 (86.2%) samples of Candida were sensitive and 4(13.7%) samples were resistant to Fluconazole by broth microdilution method. \nConclusion: The Antifungal susceptibility testing by broth microdilution method revealed that fluconazole was exceedingly resistant against Candida albicans (13.7%) and increasingly susceptible to Amphotericin B (96.5%). Antifungal susceptibility testing may possibly be used to calculate the clinical response, to forecast malfunction in management. Therefore, Proper administration of antifungal drugs should be prioritized only with susceptibility result testing.","PeriodicalId":16728,"journal":{"name":"Journal of Pharmaceutical Negative Results","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Negative Results","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47750/pnr.2023.14.02.337","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Candidiasis is a major fungal infection where Candida albicans is the major cause of infections in humans.  Candida albicans is an opportunistic pathogen under immune-compromised conditions and despite anti-fungal therapies, it has become lethal. Increase in the antimicrobial resistance in C. albicans is a matter of concern as it is in the human microbiome. Aim and Objective: To determine the antifungal susceptibility pattern of Candida albicans isolated from different clinical samples against Fluconazole and Amphotericin B by Kirby Bauer disc diffusion method and Broth microdilution method. Materials and Methods: This was a cross sectional study carried out in the Department of Microbiology at Rama Medical College Hospital and Research Centre Mandhana, Kanpur for a period of 1 year i.e, April 2018 to April 2019. A total of 70 isolates of Candida species from different clincal specimens like blood, BAL, urine, Pus, Et secreation and vaginal secreation were evaluated for its susceptibility against Fluconazole and Amphotericin B using Kirby Bauer disc diffusion method and Broth micro dilution method according to the CLSI guidelines 2018. Results: Out of 70 isolates of Candida species 29 (41.4%) isolates were confirmed to be C.albicans. The ratio of Males 18 (62%) was more as compared to that of the Females 11(37.9%) with the maximum age of 31-40 being affected the most followed by 41-50 and least in the age group above 61 years of age. The number of isolates was maximum in the urine sample.  A total of 12 (41.3%) samples of Candida were sensitive and 17 (58.6%) samples were resistant to Amphotericin B & 27(93%) samples of Candida were sensitive and 2(6.8%) samples were resistant to Fluconazole by Kirby bauer disc diffusion method. 28(96.5%) samples of Candida were sensitive and 1(3.4%) sample was resistant to Amphotericin B & 25 (86.2%) samples of Candida were sensitive and 4(13.7%) samples were resistant to Fluconazole by broth microdilution method. Conclusion: The Antifungal susceptibility testing by broth microdilution method revealed that fluconazole was exceedingly resistant against Candida albicans (13.7%) and increasingly susceptible to Amphotericin B (96.5%). Antifungal susceptibility testing may possibly be used to calculate the clinical response, to forecast malfunction in management. Therefore, Proper administration of antifungal drugs should be prioritized only with susceptibility result testing.
“KIRBY-BAUER纸片扩散法和溴化微稀释法对不同临床样品中分离的白色念珠菌抗真菌敏感性模式的表型评价”
简介:念珠菌是一种主要的真菌感染,白色念珠菌是人类感染的主要原因。白色念珠菌是一种在免疫受损条件下的机会性病原体,尽管有抗真菌治疗,但它已经致命。白色念珠菌耐药性的增加是一个令人担忧的问题,就像它在人类微生物组中一样。目的:采用Kirby-Bauer纸片扩散法和Broth微量稀释法测定不同临床样品中白色念珠菌对氟康唑和两性霉素B的耐药性。材料和方法:这是在坎普尔Mandhana Rama医学院医院和研究中心微生物系进行的一项为期1年的横断面研究,即2018年4月至2019年4月。根据CLSI指南2018,使用Kirby-Bauer圆盘扩散法和Broth微量稀释法,对来自血液、BAL、尿液、Pus、Et和阴道分泌物等不同临床标本的70株念珠菌菌株进行了对氟康唑和两性霉素B的易感性评估。结果:在70株念珠菌中,29株(41.4%)被证实为白色念珠菌。男性18株(62%)的比例高于女性11株(37.9%),其中31岁至40岁的受影响最大,其次是41岁至50岁,61岁以上的受影响最小。尿液样本中的分离物数量最多。Kirby-bauer纸片扩散法共检测到12个(41.3%)念珠菌样品对两性霉素B敏感,17个(58.6%)念珠菌样品耐药,27个(93%)念珠菌样品敏感,2个(6.8%)念珠菌样品抗氟康唑。用肉汤微量稀释法检测28例(96.5%)念珠菌敏感,1例(3.4%)对两性霉素B耐药,25例(86.2%)念珠菌敏感和4例(13.7%)对氟康唑耐药。结论:用肉汤微量稀释法检测氟康唑对白色念珠菌的耐药性为13.7%,对两性霉素B的敏感性为96.5%,可用于临床疗效的计算和管理失误的预测。因此,只有在进行药敏结果检测时,才应优先考虑正确使用抗真菌药物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信